early disease
In all patients, early disease stage, good ECOG, normal neuron-specific enolase (NSE), thoracic radiotherapy, >= 4 cycles of chemotherapy, prophylactic cranial irradiation, good response to initial therapy were independent favorable prognostic factors for OS, along with gender, age, CEA and CA125.